Mode
Text Size
Log in / Sign up

Moral Injury

Part of Post-Traumatic Stress Disorder

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Moral Injury

6 trials tracked for Moral Injury: 1 in phase 3 or 4 and 1 with published results. The most-cited published study has 36 citations.

6Trials tracked
1Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 1 Other / NA 5
  1. Phase 3 Frontline Clinician Psilocybin Study Completed · 36 cited
  2. N/A Thriving in the Midst of Moral Pain: The Acceptability and Feasibility of Acceptance and Commitment Therapy for Moral Injury (ACT-MI) Among Warzone Veterans Completed
  3. N/A Psychosocial Rehabilitation After Moral Injury and Loss With Adaptive Disclosure Completed
  4. N/A Pilot Study Testing a Web-Based Moral Elevation Intervention for Veterans With PTSD and Moral Injury Completed
  5. N/A Mindful Self Compassion for Combat Deployed Veterans With Moral Injury and Co-occurring PTSD-SUD Completed
  6. N/A A Novel Posttraumatic Stress Disorder Treatment for Veterans With Moral Injury Completed

Showing the 6 most-cited and recently-updated of 6 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

What the trials found For clinicians

Moral Injury: what the trials found

Psilocybin (Usona Institute) is being investigated in a Phase 3 trial for moral injury 1. No outcome results are available yet.

Acceptance and Commitment Therapy for Moral Injury (ACT-MI) has been studied in a recent trial 2.

Impact of Killing (IOK) showed no significant difference in quality of life (WHOQOL-BREF, p=0.975) or PTSD symptoms (CAPS-5, p=0.831) compared to control 3.

Recent results — preliminary, needs further review

  • Adaptive Disclosure for Moral Injury and Loss showed a significant improvement in functional impairment (SDS, p=0.03) but not in psychosocial functioning (B-IPF, p=0.35) 4.
  • Mindful Self-Compassion reduced alcohol use days from baseline at post-treatment (-24.30 days) and 1-month follow-up (-26.20 days) in a small trial 5.
  • Moral Elevation intervention is being studied 6.

For the clinician treating this condition

  • Psilocybin is under Phase 3 investigation; no efficacy data available yet 1.
  • Impact of Killing (IOK) did not improve quality of life or PTSD symptoms 3.
  • Adaptive Disclosure may improve functional impairment but not psychosocial functioning 4.

AI synthesis of 6 cited trials, updated Jun 29, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.